SeqOne has partnered with MGI Tech to develop comprehensive genomic analysis solutions tailored for human genetics and pathology laboratories worldwide.
The partnership will validate an automated solution for HRD signature with MGI's DNBSEQ-G99 for efficient and high-quality HRD testing, which will benefit pathology molecular labs globally. It also aims to integrate and validate SeqOne’s tertiary analysis solution with MGI's MegaBOLT bioinformatics analysis accelerator. It offers an efficient solution from samples to reports for high-throughput Human Genetics labs. Lastly, the partnership will validate SeqOne's germline and somatic analysis platform for routine use with MGI sequencers.
Headquartered in France, SeqOne Genomics is a health tech company specializing in genomic analysis tools for clinical applications. SeqOne leverages AI to transform genomic data into actionable medical insights, particularly in oncology and rare genetic diseases.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.